Latest Tuberculosis treatment Stories
New multi-year grant continues work to study pressing public health crisis TUCSON, Ariz., Sept.
NEW YORK, Aug.
Brock Will Lead Resource Development, Advocacy, Community Engagement Efforts in Support of Promising Research Pipeline NEW YORK, July 31, 2014 /PRNewswire-USNewswire/
Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the
Tuberculosis infection among people taking corticosteroid pills may be underestimated.
Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates NEW YORK, May 14, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization
Partnership Supports Newly Announced STAND Trial SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- TB Alliance, an international non-profit drug development organization that develops
STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/
Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine,
IBM's Big Data analytics to help crack the code of the tuberculosis genome and uncover new diagnosis and treatment approaches DURBAN, South Africa, March 24, 2014 /PRNewswire/ -- On
- A trick or prank.